v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Aug. 01, 2026
Aug. 02, 2025
Cash flows from operating activities:    
Net income $ 3,347,266 $ 1,479,604
Adjustments to reconcile net income to net cash provided by operations:    
Depreciation 315,298 301,323
Amortization of intangibles 1,160,358 1,202,179
Stock-based compensation expense 263,651 235,108
Deferred income taxes (281,941) (97,318)
Other (19,377) (1,496)
Changes in operating assets and liabilities (940,740) (8,008)
Total adjustments 497,249 1,631,788
Net cash provided by operating activities 3,844,515 3,111,392
Cash flows from investing activities:    
Purchases of short-term available-for-sale investments 0 (1,150,240)
Maturities of short-term available-for-sale investments 990,657 372,778
Additions to property, plant and equipment, net (392,677) (318,399)
Proceeds from sale of property, plant and equipment, net 0 58,892
Proceeds from sale of a subsidiary, net 96,592 0
Payments for acquisitions, net of cash acquired (1,536,049) (45,652)
Other (32,425) (13,595)
Net cash used for investing activities (873,902) (1,096,216)
Cash flows from financing activities:    
Proceeds from debt 0 1,490,785
Debt repayments 0 (399,998)
Proceeds from commercial paper notes 13,061,198 6,867,508
Payments of commercial paper notes (12,502,732) (6,866,581)
Repurchase of common stock (2,446,409) (1,484,166)
Dividend payments to shareholders (1,556,028) (1,437,521)
Proceeds from employee stock plans 121,171 104,329
Other 18,651 40,317
Net cash used for financing activities (3,304,149) (1,685,327)
Net (decrease) increase in cash and cash equivalents (333,536) 329,849
Cash and cash equivalents at beginning of period 2,499,406 1,991,342
Cash and cash equivalents at end of period $ 2,165,870 $ 2,321,191